Blog | HemaCare

Regulating T Cells May Help Them Kill Again

Jul 22, 2015 1:00:22 PM / by Maria posted in Regulatory T Cells, vitamin D, Basic Research, Immunotherapy (Immunology)

0 Comments

Killer T cells launch an aggressive attack but don't last for long. Scientists are working on ways to draw a few back to a subdued memory form.

It does well to remember your enemies. When the human body encounters an infectious agent for the first time, it (often) successfully beats back the intruder by expanding in great number the immune cells that are specially equipped to clear out the pathogens and infected cells. After health is restored, a few "memory" versions of these immune cells remain, such that, should the infectious agent make a second unwelcome appearance, the immune response is quicker and more intense.

Read More

Quality Tregs: HemaCare Develops a New Treg Enrichment Protocol

Apr 27, 2015 1:00:12 PM / by Maria posted in Autoimmune Disorders, Cancer, Regulatory T Cells

0 Comments

Enriched Tregs prepared by HemaCare are useful for a multitude of research applications

Read More

Tregs opens up Exciting Opportunities for Cell Based Therapies

Sep 22, 2014 1:00:40 PM / by Shweta posted in Cell Therapy, Regulatory T Cells, Whole Blood, GMP Cellular Therapeutics, Basic Research

0 Comments

Manufacturing of clinical grade Tregs for cell based therapies

Graft-versus-host disease (GVHD) is a grave matter of concern for allogeneic hematopoietic stem cell transplantation (HSCT) where newly transplanted donor cells regard the recipient's body as foreign and attack them. This life-threatening complication is due to the fact that donor T-cells, present within the transplant recognize recipient major and/or minor histocompatibility antigens, become activated and attack target organs of GVHD. Although a variety of pharmacologic agents are available, such as calcineurin inhibitors and steroids to boost the tolerance against the clinical transplantation still more than 50% of severe GVHD patients are refractory to these current therapies[1]. Moreover, the long-term use of such agents impairs immune reconstitution, and diminishes T-cell mediated graft-versus-leukemia (GVL) responses. Therefore, there is a pressing need to develop specific cell-based therapies which may offer alternative approaches to prevent and/or to control severe GVHD.

Read More

Regulatory T cells can Counteract Fungi

Jul 30, 2014 1:23:18 PM / by Maria posted in Regulatory T Cells, T Cells, Immunotherapy (Immunology)

0 Comments

Read More

New Type of Treg Cells Combat Brain Atrophy

May 14, 2014 1:00:22 PM / by Maria posted in Gene Therapy, apoptosis, Autoimmune Disorders, Cell Therapy, Inflammation, leukocyte differential, Regulatory T Cells, white blood cells, Basic Research

0 Comments

Immunosuppressive properties of novel FoxA1 expressing Treg cells can be exploited for multiple sclerosis treatment

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts